MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12245-026-01170-9

Медицинская библиотека · International journal of emergency medicine · 2026

Starvation ketoacidosis associated with tirzepatide use for weight loss in a non-diabetic East Asian woman: a case report.

Minoda Yuki, Ikeda Syuhei, Inukai Koichi, Kishitani Suguru, Takeuchi Takamasa, Aikawa Hirohiko, Saito Ken, Kittaka Hirotada, Hayashi Yasuyuki, Sawano Hirotaka, Ito Yusuke

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, is increasingly used for obesity treatment, including in individuals without diabetes. Starvation ketoacidosis is a rare but serious complication associated with reduced caloric intake and enhanced ketogenesis. Reports of tirzepatide-associated starvation ketoacidosis in non-diabetic patients remain limited, and none have been reported in East Asian populations.

CASE PRESENTATION: A 21-year-old Japanese woman with obesity initiated weekly subcutaneous tirzepatide (2.5 mg/week) for weight loss while practicing carbohydrate restriction. After the fifth injection, she developed persistent nausea and vomiting, leading to markedly reduced oral intake. She presented to the emergency department with hypoglycemia (68 mg/dL) and severe high-anion gap metabolic acidosis (pH 7.22, bicarbonate 10 mmol/L, anion gap 22.6 mmol/L). Urinalysis revealed ketonuria, and serum ketone levels were markedly elevated. She had lost 21 kg one month after the initiation of tirzepatide. No infection, toxin exposure, or alternative metabolic disorder was identified. Starvation ketoacidosis was diagnosed. Treatment with intravenous glucose-containing fluids resulted in rapid resolution of metabolic acidosis within 12 h without insulin therapy.

CONCLUSIONS

This case demonstrates that tirzepatide can precipitate starvation ketoacidosis in non-diabetic individuals, particularly when gastrointestinal adverse effects or dietary restriction lead to caloric deprivation. As the first reported case in an East Asian patient, it highlights the need for emergency physicians to consider starvation ketoacidosis in patients using tirzepatide for weight loss who present with vomiting, poor intake, or rapid weight loss. Early recognition and appropriate metabolic assessment are essential, and in patients with preserved endogenous insulin secretion, prompt glucose administration may allow rapid recovery without need for insulin therapy.

Для цитирования: Minoda Yuki, Ikeda Syuhei, Inukai Koichi, Kishitani Suguru, Takeuchi Takamasa, Aikawa Hirohiko, Saito Ken, Kittaka Hirotada, Hayashi Yasuyuki, Sawano Hirotaka, Ito Yusuke. Starvation ketoacidosis associated with tirzepatide use for weight loss in a non-diabetic East Asian woman: a case report.. International journal of emergency medicine. 2026. DOI: 10.1186/s12245-026-01170-9.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.